Terms: = Bone cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28 AND Diagnosis
34 results:
1. Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of
Gheorghe AM; Sima OC; Florescu AF; Ciuche A; Nistor C; Sandru F; Carsote M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396977
[TBL] [Abstract] [Full Text] [Related]
2. A family case report of parathyroid carcinoma associated with
Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
[TBL] [Abstract] [Full Text] [Related]
3. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
Diao Z; Zhang J; Zhao J; Sun W; Pu Z
BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
[TBL] [Abstract] [Full Text] [Related]
4. The evolution of primary hyperparathyroidism publications and global productivity from past to present: A bibliometric analysis during 1980 to 2022.
Göbüt H; Bostanci H
Medicine (Baltimore); 2023 Sep; 102(35):e34622. PubMed ID: 37657020
[TBL] [Abstract] [Full Text] [Related]
5. Para This, Fibromin That: The Role of cdc73 in Parathyroid Tumors and Familial Tumor Syndromes.
Ababneh E; Nosé V
Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170
[TBL] [Abstract] [Full Text] [Related]
6. Rare duplication of the cdc73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
Garrigues G; Batisse-Lignier M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kelly A; Gay-Bellile M; Viala S; Bidet Y; Bignon YJ; Cavaillé M
Mol Genet Genomic Med; 2023 May; 11(5):e2133. PubMed ID: 36639964
[TBL] [Abstract] [Full Text] [Related]
7. diagnosis and management of parathyroid carcinoma: a state-of-the-art review.
Roser P; Leca BM; Coelho C; Schulte KM; Gilbert J; Drakou EE; Kosmas C; Ling Chuah L; Wassati H; Miras AD; Crane J; Aylwin SJB; Grossman AB; Dimitriadis GK
Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36621911
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
9. A two-generation hyperparathyroidism-jaw tumor (hpt-jt) syndrome family: clinical presentations, pathological characteristics and genetic analysis: a case report.
Yang D; Zheng J; Tang F; He Q; Huang H; Zhou P
Diagn Pathol; 2022 Sep; 17(1):71. PubMed ID: 36153594
[TBL] [Abstract] [Full Text] [Related]
10. Expression of Beta-Catenin, Cadherins and P-Runx2 in Fibro-Osseous Lesions of the Jaw: Tissue Microarray Study.
Pannone G; Nocini R; Santoro A; Spirito F; Nocini PF; Papagerakis S; Franceschi RT; Di Domenico M; Di Carlo A; Danelia N; Lo Muzio L
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454175
[TBL] [Abstract] [Full Text] [Related]
11. Genetics and Epigenetics of Parathyroid Carcinoma.
Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
[TBL] [Abstract] [Full Text] [Related]
12. Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
Saponaro F; Pardi E; Mazoni L; Borsari S; Torregrossa L; Apicella M; Frustaci G; Materazzi G; Miccoli P; Basolo F; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4565-e4579. PubMed ID: 34157106
[TBL] [Abstract] [Full Text] [Related]
13. [Primary hyperparathyroidism in Russia according to the registry].
Mokrysheva NG; Mirnaya SS; Dobreva EA; Maganeva IS; Kovaleva EV; Krupinova JA; Kryukova IV; Tevosyan LK; Lukyanov SV; Markina NV; Bondar IA; Podprugina NG; Ignatieva IA; Shabelnikova OY; Dreval AV; Antsiferov MB; Mel'nichenko GA; Dedov II
Probl Endokrinol (Mosk); 2019 Nov; 65(5):300-310. PubMed ID: 32202734
[TBL] [Abstract] [Full Text] [Related]
14. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
Cetani F; Marcocci C; Torregrossa L; Pardi E
Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
[TBL] [Abstract] [Full Text] [Related]
15. Challenges in the treatment of parathyroid carcinoma: a case report.
Russo M; Borzì G; Ilenia M; Frasca F; Malandrino P; Gullo D
Hormones (Athens); 2019 Sep; 18(3):325-328. PubMed ID: 30905030
[TBL] [Abstract] [Full Text] [Related]
16. Previously unreported deletion of cdc73 involving exons 1-13 was detected in a patient with recurrent parathyroid carcinoma.
Mahajan G; Sacerdote A
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567092
[TBL] [Abstract] [Full Text] [Related]
17. Parathyroid carcinoma.
Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
[TBL] [Abstract] [Full Text] [Related]
18. cdc73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.
Vocke CD; Ricketts CJ; Ball MW; Schmidt LS; Metwalli AR; Middelton LA; Killian JK; Khan J; Meltzer PS; Simonds WF; Merino MJ; Linehan WM
Urology; 2019 Feb; 124():91-97. PubMed ID: 30452964
[TBL] [Abstract] [Full Text] [Related]
19. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing.
Koikawa K; Okada Y; Mori H; Kawaguchi M; Uchino S; Tanaka Y
Intern Med; 2018 Mar; 57(6):841-844. PubMed ID: 29225260
[TBL] [Abstract] [Full Text] [Related]
20. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel cdc73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract] [Full Text] [Related]
[Next]
